If you missed it at DDL, you can now download a copy of the poster we displayed at the conference last week. The title of the poster was “Development of HFA-152a as a sustainable pMDI propellant”   Click the link below ZEPHEX_DDL_A0_Artwork

Landmark multi-million-pound sterling commercial agreement will advance efforts to bring Zephex®152a from the laboratory to the patient   Runcorn (United Kingdom) December 2019 – Koura, the leading medical propellant manufacturer (previously known as Mexichem Fluor), has today announced a commercial agreement to supply the new…

Global innovators and world leaders in medical propellants, Koura, will showcase its industry-leading products at The Drug Delivery to the Lungs (DDL) Conference as a Gold Sponsor.

Leading medical propellant manufacturer and supplier, Koura, have announced a multi million-pound investment into a new laboratory facility based at their new medical division HQ at Thornton Science Park, Chester, UK. The facility will be the first in the world to offer dedicated pharmaceutical grade…

The invaluable innovations that come from future generations will change the world, which is why Orbia provides the tools for young people to learn through…

We spoke to Tipu Salahuddin, Operations Director for Koura’s Fluorochemicals Division about global operations and managing a day across very different time zones.

With the University of Manchester, Stuart Corr, our Technology Commercial Director studied reducing carbon footprints in metered-dose inhalers. The researchers’ findings were published…